12.79
2.65%
0.33
Day One Biopharmaceuticals Inc (DAWN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.18%
66.77
|
59.52 | 51.44 | 49.25 | 45.85 |
Operating Income/Loss |
12.18%
-66.77
|
-59.52 | -51.44 | -49.25 | -45.85 |
Income/Loss From Continuing Operations Before Tax |
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
Income/Loss From Continuing Operations After Tax |
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
Net Income/Loss
|
14.49%
-62.41
|
-54.51 | -46.15 | -45.86 | -42.39 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,046%
86.68
|
2.0908 | 85.95 | 74.96 | 71.97 |
Diluted Average Shares |
4,046%
86.68
|
2.0908 | 85.95 | 74.96 | 71.97 |
Basic Earnings Per Share |
12.50%
-0.72
|
-0.64 | -0.54 | -0.61 | -0.59 |
Diluted Earnings Per Share |
12.50%
-0.72
|
-0.64 | -0.54 | -0.61 | -0.59 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):